Effect of Mitochondria‐Derived Methylmalonic Acid on Progress and Mortality Risk in US Adults With Cardiovascular‐Kidney‐Metabolic Syndrome
Mitochondria-derived MMA may serve as a valuable biomarker for evaluating CKM progression and mortality risk in individuals with CKM.
Authors
- Tommaso Bucci (ORCID: https://orcid.org/0000-0003-2895-6234)
- Y Wang
- Yang Chen (ORCID: https://orcid.org/0000-0002-5773-238X)
- Bi Huang
- Ziyi Zhong
- Chunyu Liu
- Manlin Zhao
- Yang Liu
- Gregory Y.H. Lip
- Hongyu Liu
- Kui Hong
- Shuang Wu
Institutions
- Zhejiang Chinese Medical University (CN)
- Nanchang University (CN)
- Medical University of Białystok (PL)
- University of Liverpool (GB)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Liverpool Heart and Chest Hospital (GB)
- National Clinical Research (US)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Liverpool John Moores University (GB)
- Sapienza University of Rome (IT)
- Chongqing Medical University (CN)
- Aalborg University (DK)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1161/jaha.125.043066
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00